Using puppets to help children with inhaler treatment
The Effect of Preparation With The Ventriloquist Puppet Method Before Inhaler Treatment on Anxiety and Fear Level of Children Aged 4-6
This study tests whether using puppets can help young children feel less anxious about using inhalers during their treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 4 Years to 6 Years |
| Sex | All |
| Sponsor | Karamanoğlu Mehmetbey University Academic / other |
| Locations | 1 site (Karaman) |
| Trial ID | NCT06162598 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of the ventriloquist puppet method on reducing anxiety and fear in children aged 4-6 who are undergoing inhaler treatment. By utilizing puppets as a therapeutic tool, the study aims to improve children's compliance with medical procedures and enhance their overall treatment experience. The approach focuses on preparing children emotionally before treatment, addressing their fears associated with hospital visits and medical interventions. The study involves children who can communicate in Turkish and are willing to participate voluntarily.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 4-6 who are receiving inhaler therapy and can communicate in Turkish.
Not a fit: Children with cognitive or mental problems, life-threatening conditions, or sensory impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this method could significantly reduce anxiety in young children during inhaler treatments, leading to better treatment compliance.
How similar studies have performed: Previous studies have shown that puppet-based interventions can effectively reduce anxiety in children during medical procedures, suggesting a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children between the ages of 4-6, * Children receiving inhaler therapy, * Children and families who can speak Turkish, * Children and families who volunteer to participate in the research, Exclusion Criteria: * Children with cognitive or mental problems, * Children with life-threatening conditions, * Children with hearing, vision and/or speech impairments
Where this trial is running
Karaman
- Tuba ARPACI — Karaman, Turkey (Recruiting)
Study contacts
- Principal investigator: Tuba ARPACI, PhD — Karamanoğlu Mehmetbey University
- Study coordinator: Tuba ARPACI, PhD
- Email: tubaarpaci25@gmail.com
- Phone: +905306401928
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.